Moreover, these mechanistic findings are clinically relevant because (1) RIPK2 and MYC are frequently co-amplified/gained in lethal PC and several other cancer types, and (2) RIPK2 and MYC activity scores are strongly correlated in clinical tissue specimens of 32 cancer types. The gene discussed is RIPK2; the disease is pachyonychia congenita.